Entero Therapeutics' auditor Forvis Mazars resigns over financial reporting reliability concerns

GridAI Technologies Corp.

Forvis Mazars resigned as independent auditor on Aug 9, 2024, citing belief that cost reduction measures prevent reliable financial reporting.
Company disagrees with auditor's belief and states it has sufficient management and governance.
Forvis Mazars was appointed on June 1, 2024 and never issued audit reports for fiscal years 2022 and 2023.
Board appointed Timothy R. Ramdeen as new director; he brings life science investment experience.
Board filled audit committee vacancies: Chaitan Khosla and Alastair Riddell appointed, Edward Borkowski named Audit Chair and Compensation Committee Chair.

item 4.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Timothy R. Ramdeen

Director

GRDX · GridAI Technologies Corp.

Effective: 2024-08-09
Filed: August 15, 2024, 7:59 PM ET

appointed Timothy R. Ramdeen as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy R. Ramdeen was appointed as Director at GridAI Technologies Corp..

Action: appointed
Role: Director

Exact text from the filing

appointed Timothy R. Ramdeen as a member of the Board.

View on SEC.gov

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001104659-24-089923

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.